Cargando…
High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
BACKGROUND: DARS2 was overexpressed in multiple tumor types, but the biological role of DARS2 in lung adenocarcinoma (LUAD) have not been elucidated. METHODS: Firstly, the DARS2 expression in LUAD was explored using The Cancer Genome Atlas (TCGA). Then, qRT‐PCR and Western blot were performed to con...
Autores principales: | Jiang, Yingfeng, You, Jianbin, Wu, Chuncai, Kang, Yanli, Chen, Falin, Chen, Liangyuan, Wu, Wenbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550967/ https://www.ncbi.nlm.nih.gov/pubmed/36085578 http://dx.doi.org/10.1002/jcla.24691 |
Ejemplares similares
-
Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022) -
Serum and Serum Exosomal CircRNAs hsa_circ_0001492, hsa_circ_0001439, and hsa_circ_0000896 as Diagnostic Biomarkers for Lung Adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022) -
Plasma tRF-1:29-Pro-AGG-1-M6 and tRF-55:76-Tyr-GTA-1-M2 as novel diagnostic biomarkers for lung adenocarcinoma
por: You, Jianbin, et al.
Publicado: (2022) -
CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator
por: Zhang, Li, et al.
Publicado: (2016) -
Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)